Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes. - Wikidata - wikimedia - TriplyDB

Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes.

Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes.

http://www.wikidata.org/entity/Q30758454

about

Capsule Commentary on Melzer et al., Predictors of Pharmacotherapy for Tobacco Use among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes.Association between race and receipt of counselling or medication for smoking cessation in primary care.

P2860

Q42781074-3722819A-E877-4EEE-982C-19A70CF1D498 Q46271355-28A529B9-6E22-4513-9DF7-EFF9C82FEE1E

P2860

Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes.

http://www.wikidata.org/entity/Q30758454

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Predictors of Pharmacotherapy ...... and Tobacco Control Processes.

@ast

Predictors of Pharmacotherapy ...... and Tobacco Control Processes.

@en

type

label

Predictors of Pharmacotherapy ...... and Tobacco Control Processes.

@ast

Predictors of Pharmacotherapy ...... and Tobacco Control Processes.

@en

prefLabel

Predictors of Pharmacotherapy ...... and Tobacco Control Processes.

@ast

Predictors of Pharmacotherapy ...... and Tobacco Control Processes.

@en

P1433

Q30758454-F99151A7-2F66-4942-B456-1DF3692DACAE

P1476

Q30758454-4B678644-C9C4-4B87-945F-777BB450FAD3

P2093

Q30758454-008B4607-4669-4107-B855-A4E34C4BF9A6

Q30758454-70A2FEFE-CF67-4F4B-8E12-2293A51B3F58

Q30758454-77648197-A3DE-4CB3-A1D8-9BC36837C6F9

Q30758454-7E20D5BC-D588-458B-BC81-70C5382CF14A

P2860

Q30758454-02412CB8-39BD-418A-AE87-9B0A25F2FD03

Q30758454-10AF75AE-6F36-42C8-A181-B5C554AB3868

Q30758454-14C25615-AC11-47C0-A63D-B87668B13A03

Q30758454-175E811B-3C99-452B-9934-7E566C8C7D6D

Q30758454-1EB211AD-0DE4-4BEB-9964-55E8801BE98A

Q30758454-2392862A-FBF8-4855-8505-0B48921A420C

Q30758454-292FB4C1-CDF4-4D54-9CEC-40267B074CFC

Q30758454-2B79F1B9-3690-4662-ADA6-1D7A63837B61

Q30758454-2E39AF83-0E88-49CE-AFC5-3E0AA537D22C

Q30758454-30922464-B34E-4962-ABE8-7CFAF9925A9E

P2888

Q30758454-B362956D-ACBA-4C98-9ADC-7DA38A7490EB

P304

Q30758454-0A1C9FD5-AAAC-4A2A-BD41-350CA6D0F866

P31

Q30758454-23E3A968-8CE5-4C50-82DA-200F1400FB72

P356

Q30758454-D7BBD951-92BA-45D7-B441-D23FF0A11B8C

P433

Q30758454-6853C0EB-92B6-4407-B8C4-73B94EA6BF15

P478

Q30758454-E87B3348-F5B5-44DE-B018-B7D2C2BA37B4

P577

Q30758454-1D626D80-ACA6-491F-A10F-8B328C482066

P6179

Q30758454-027336C8-5C15-4B0F-BB49-93D53B1C6AF9

P698

Q30758454-2D53EF32-D6A0-46C8-B367-106EC8E423F8

P921

Q30758454-7AD3BEB9-2F85-425E-95D3-9FF7013A0E41

Q30758454-AB81A27F-761D-4970-85E0-8ED5A45D839B

Q30758454-F497B4C9-5BFD-423D-92B2-8B9D068DFD29

P932

Q30758454-7878A7E8-5925-4548-8668-F870C0DB09B7

P356

S11606-016-3623-4

P1433

Journal of General Internal Medicine

P1476

Predictors of Pharmacotherapy ...... and Tobacco Control Processes.

@en

P2093

Anne C Melzer

http://www.w3.org/2001/XMLSchema#string

David H Au

http://www.w3.org/2001/XMLSchema#string

Laura C Feemster

http://www.w3.org/2001/XMLSchema#string

Margaret P Collins

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions for smoking cessation in hospitalised patients.

The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD

Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early I

Socioeconomic status, race and COPD health outcomes

Missing potential opportunities to reduce repeat COPD exacerbations.

Comorbidity measures for use with administrative data.

Smoking and mental illness: results from population surveys in Australia and the United States

Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source.

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

P2888

s11606-016-3623-4

P304

623-629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11606-016-3623-4

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043574311

http://www.w3.org/2001/XMLSchema#string

P698

26902236

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

pharmacotherapy

P932

4870422

http://www.w3.org/2001/XMLSchema#string